| Literature DB >> 28110956 |
Hong-Jie Zhang1, Emily Rumschlag-Booms2, Yi-Fu Guan3, Kang-Lun Liu3, Dong-Ying Wang3, Wan-Fei Li3, Van Hung Nguyen4, Nguyen Manh Cuong5, Djaja Doel Soejarto6, Harry H S Fong6, Lijun Rong7.
Abstract
In a search for new anti-HIV active leads from over several thousands of plant extracts, we have identified a potent plant lead. The active plant is determined as Justicia gendarussa (Acanthaceae), a medicinal plant that has been used for the treatment of injury, arthritis and rheumatism in Asia including China. Our bioassay-guided fractionation of the methanol extract of the stems and barks of the plant led to the isolation of two anti-HIV compounds, justiprocumins A and B. The compounds are identified as new arylnaphthalide lignans (ANL) glycosides. We further determined that the ANL glycosides are the chemical constituents that contribute to the anti-HIV activity of this plant. Justiprocumin B displayed potent activity against a broad spectrum of HIV strains with IC50 values in the range of 15-21 nM (AZT, IC50 77-95 nM). The compound also displayed potent inhibitory activity against the NRTI (nucleoside reverse transcriptase inhibitor)-resistant isolate (HIV-11617-1) of the analogue (AZT) as well as the NNRTI (non-nucleoside reverse transcriptase inhibitor)-resistant isolate (HIV-1N119) of the analogue (nevaripine).Entities:
Keywords: Acanthaceae; Anti-HIV; Antiviral activity; Arylnaphthalide lignans glycosides; Justicia gendarussa; Justiprocumins; NRTI- and NNRTI-resistant HIV-1 variants; Plant natural products
Mesh:
Substances:
Year: 2017 PMID: 28110956 DOI: 10.1016/j.phytochem.2017.01.005
Source DB: PubMed Journal: Phytochemistry ISSN: 0031-9422 Impact factor: 4.072